SIMPLEX TRADING, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$463
+7616.7%
11,174
+11074.0%
0.00%
Q1 2023$6
-79.3%
100
-74.9%
0.00%
Q4 2022$29
-99.8%
398
+101.0%
0.00%
Q3 2022$15,000
-86.1%
198
-87.4%
0.00%
Q2 2022$108,000
-83.1%
1,568
-79.6%
0.00%
-100.0%
Q1 2022$638,000
-21.3%
7,705
-28.7%
0.00%0.0%
Q4 2021$811,000
-54.2%
10,807
+15.8%
0.00%
-50.0%
Q3 2021$1,770,000
-25.8%
9,332
-13.2%
0.00%0.0%
Q2 2021$2,384,000
+118.5%
10,748
+30.1%
0.00%0.0%
Q1 2021$1,091,000
+2271.7%
8,260
+3005.3%
0.00%
Q4 2020$46,000
+58.6%
2660.0%0.00%
Q3 2020$29,000
-95.0%
266
-97.3%
0.00%
-100.0%
Q2 2020$580,000
+4361.5%
9,791
+4795.5%
0.00%
Q1 2020$13,000
-98.8%
200
-98.6%
0.00%
-100.0%
Q3 2019$1,060,000
-8.2%
14,177
-22.4%
0.00%0.0%
Q2 2019$1,155,000
+377.3%
18,267
+152.2%
0.00%
+200.0%
Q4 2018$242,000
-41.0%
7,243
-7.6%
0.00%0.0%
Q3 2018$410,000
+3053.8%
7,842
+1711.1%
0.00%
Q2 2018$13,000
-89.4%
433
-92.9%
0.00%
-100.0%
Q4 2017$123,000
+141.2%
6,132
+135.9%
0.01%
+150.0%
Q3 2017$51,000
-53.2%
2,599
-59.0%
0.00%
-60.0%
Q2 2017$109,000
-50.7%
6,332
-77.5%
0.01%
-61.5%
Q4 2016$221,000
+531.4%
28,190
+832.5%
0.01%
+550.0%
Q2 2016$35,0003,0230.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders